Related references
Note: Only part of the references are listed.Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
Thomas Grunwald et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation
Qian Wang et al.
BIOMATERIALS (2014)
Porous nucleating agents for protein crystallization
Sahir Khurshid et al.
NATURE PROTOCOLS (2014)
PDBsum additions
Tjaart A. P. de Beer et al.
NUCLEIC ACIDS RESEARCH (2014)
Letter from the Editor
Ronald Ellis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Recombinants proteins for industrial uses: utilization of Pichia pastoris expression system
Claudia Rabert et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2013)
The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas
Kristina M. Bacon et al.
VACCINE (2013)
The Economic Value of a Visceral Leishmaniasis Vaccine in Bihar State, India
Bruce Y. Lee et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
The future of human DNA vaccines
Lei Li et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Purine salvage in Leishmania: complex or simple by design?
Jan M. Boitz et al.
TRENDS IN PARASITOLOGY (2012)
Leishmaniasis: complexity at the host-pathogen interface
Paul Kaye et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
Moses O. Oyewumi et al.
EXPERT REVIEW OF VACCINES (2010)
Oral immunization with Porphyromonas gingivalis outer membrane protein and CpG oligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity
C. Liu et al.
MOLECULAR ORAL MICROBIOLOGY (2010)
Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell-Driven Protective Response
Dirlei Nico et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases
Dennis M. Klinman et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective
Nicolas Guex et al.
ELECTROPHORESIS (2009)
Microbial factories for recombinant pharmaceuticals
Neus Ferrer-Miralles et al.
MICROBIAL CELL FACTORIES (2009)
A COMBINATION DNA VACCINE ENCODING NUCLEOSIDE HYDROLASE 36 AND GLYCOPROTEINE 63 PROTECTS FEMALE BUT NOT MALE HAMSTERS AGAINST LEISHMANIA MEXICANA
W. G. Chale-Balboa et al.
PARASITE (2009)
Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses
Min Liu et al.
VACCINE (2007)
The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome
Mahmoud R. Jaafari et al.
VACCINE (2007)
Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani
R. Gamboa-Leon et al.
VACCINE (2006)
Absolute quantification of proteins by LCMSE - A virtue of parallel MS acquisition
JC Silva et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model
K Mori et al.
JOURNAL OF VIROLOGY (2005)
Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis
I Aguilar-Be et al.
INFECTION AND IMMUNITY (2005)
Degradation kinetics of high molecular weight poly (L-lactide) microspheres and release mechanism of lipid:DNA complexes
MM Patel et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion
CHM Kocken et al.
INFECTION AND IMMUNITY (2002)
Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection
EG Rhee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
A nonspecific nucleoside hydrolase from Leishmania donovani:: implications for purine salvage by the parasite
LW Cui et al.
GENE (2001)
Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani
EP de Souza et al.
VACCINE (2001)
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
P Johansen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Share Paper
